Omega Healthcare Investors Inc.
OHI
$50.40
-1.89%
Omega Healthcare Investors Inc. is a real estate investment trust (REIT) that invests in healthcare-related properties, primarily skilled nursing and assisted living facilities, across the United States, the United Kingdom, and Canada. As a leading triple-net lease REIT focused on the skilled nursing sector, it differentiates itself through long-term leases with operators and a diversified portfolio. The current investor narrative centers on the company's strong revenue growth and improving occupancy trends in skilled nursing, alongside debates about operator credit quality and the sustainability of its high dividend yield.…
OHI
Omega Healthcare Investors Inc.
$50.40
Related headlines
Investment Opinion: Should I buy OHI Today?
Rating: Hold. Omega Healthcare Investors is a well-run REIT with strong revenue growth and high margins, but its current valuation near the 52-week high and analyst targets implying slight downside suggest limited near-term upside. The consensus analyst rating is Buy (mean 2.4), with an average target of $50.89, indicating the stock is fairly valued. The thesis is that Omega's solid fundamentals and high dividend yield (5.94%) provide a stable income stream, but the stock may not appreciate significantly from current levels.
Supporting Evidence: Revenue grew 16.7% YoY to $323.0M in Q1 2026, and net margin is 46.8%, well above the industry average. The trailing P/E of 21.95x is a premium to the sector median of ~18x, but the PEG ratio of 0.77 suggests undervaluation relative to growth. Free cash flow of $907.1M TTM provides strong dividend coverage, and the company has a healthy balance sheet with a debt-to-equity ratio of 0.82. The implied upside to the average analyst target is -1.6%, while the high target of $63.00 offers 21.8% upside.
Risks & Conditions: The biggest risks are operator credit quality and interest expense. If the payout ratio remains above 100% and FCF declines, the dividend could be at risk. This Hold rating would upgrade to Buy if the stock pulls back to the $45-$48 range (near the low target) or if revenue growth accelerates above 20%. It would downgrade to Sell if operator defaults increase or if the dividend is cut. Overall, Omega appears fairly valued relative to its history and peers, with a slight premium justified by its superior margins and growth.
Sign up to view all
OHI 12-Month Price Forecast
Omega Healthcare Investors has solid fundamentals with accelerating revenue and high margins, but the stock's valuation near the 52-week high limits upside potential. The base case scenario of modest growth and stable dividends is most likely, with a 55% probability. The bull case (25% probability) requires continued occupancy improvements and lower rates, while the bear case (20% probability) involves operator credit stress. The neutral stance reflects the balanced risk/reward at current levels. An upgrade to bullish would require a pullback to the $45-$48 range or a clear catalyst like a dividend increase. A downgrade to bearish would follow operator defaults or a dividend cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Omega Healthcare Investors Inc.'s 12-month outlook, with a consensus price target around $51.47 and implied upside of +2.1% versus the current price.
Average Target
$51.47
0 analysts
Implied Upside
+2.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$45 - $63
Analyst target range
Omega Healthcare Investors is covered by 18 analysts, with a consensus recommendation of 'Buy' (mean rating 2.4 on a 1-5 scale, where 1 is Strong Buy). The average target price is $50.89, implying a slight downside of -1.6% from the current price of $51.72. The distribution shows 5 Strong Buy, 8 Buy, 4 Hold, and 1 Sell, indicating a bullish tilt but with caution at current levels. The target range spans from a low of $45.00 to a high of $63.00. The high target of $63.00 implies 21.8% upside and likely assumes continued occupancy improvements and margin expansion. The low target of $45.00 suggests a 13.0% downside, possibly pricing in operator credit risks or a recession. Recent rating actions show mixed signals: Barclays downgraded to Underweight in July 2026, while UBS and Citigroup maintain Buy ratings. The wide spread between low and high targets ($18.00) indicates significant uncertainty, but the overall consensus remains positive.
Bulls vs Bears: OHI Investment Factors
Omega Healthcare Investors presents a mixed picture. On the bull side, strong revenue growth (16.7% YoY), high margins (net margin 46.8%), and a low PEG ratio (0.77) support the investment case. The stock also offers a high dividend yield (5.94%) with low volatility (beta 0.57). However, bears point to the elevated payout ratio (132.2%), proximity to the 52-week high, and analyst targets implying slight downside. The most critical tension is whether the company can sustain its dividend and growth amid operator credit risks and interest expense pressures. Currently, the bull case has stronger evidence given the accelerating revenue and solid FCF, but the stock's valuation near the high end of its range warrants caution.
Bullish
- Strong Revenue Growth: Revenue grew 16.7% YoY in Q1 2026 to $323.0M, accelerating from prior quarters. This growth is driven by rent escalations and portfolio expansion, primarily in skilled nursing facilities.
- High Profitability Margins: Net margin is 46.8% and operating margin is 64.1%, both well above industry averages. Gross margin of 97.2% reflects the triple-net lease structure where tenants cover property expenses.
- Attractive PEG Ratio: PEG ratio of 0.77 suggests the stock is undervalued relative to its earnings growth. This is a key valuation metric indicating potential upside.
- Strong Free Cash Flow: TTM free cash flow is $907.1M, providing ample coverage for the dividend and supporting future investments. FCF yield is attractive for income-focused investors.
Bearish
- High Dividend Payout Ratio: Payout ratio of 132.2% on net income raises sustainability concerns. While FCF covers dividends, the high payout ratio could pressure the dividend if earnings decline.
- Stock Near 52-Week High: Current price of $51.72 is at 99.6% of the 52-week high of $51.92, limiting near-term upside. The stock may be overextended after a 32.6% gain over the past year.
- Analyst Target Implies Downside: Average analyst target of $50.89 suggests a -1.6% downside from current levels. The low target of $45.00 implies a potential -13.0% decline.
- Operator Credit Risk: As a triple-net lease REIT, Omega depends on tenant operators' financial health. Any deterioration in operator credit quality could lead to rent defaults or reduced income.
OHI Technical Analysis
Omega Healthcare Investors is in a sustained uptrend, with the stock price up 32.6% over the past year. The current price of $51.72 sits at 99.6% of its 52-week range ($38.23–$51.92), indicating the stock is near its highs and reflecting strong momentum. This positioning suggests bullish sentiment, though it also raises caution about potential overextension. Short-term momentum is accelerating: the 1-month price change is +9.2%, and the 3-month change is +11.4%, both outpacing the S&P 500's gains of 0.8% and 3.5%, respectively. This divergence from the broader market signals strong relative strength, with the stock gaining 8.4% more than the S&P over the past month. The 1-month trend aligns with the longer-term uptrend, reinforcing the bullish case. Key support lies at the 52-week low of $38.23, while resistance is at the 52-week high of $51.92. A breakout above $51.92 would signal further upside, while a breakdown below $38.23 could indicate a trend reversal. The stock's beta of 0.57 indicates it is 43% less volatile than the market, making it a lower-risk holding within a portfolio.
Beta
0.57
0.57x market volatility
Max Drawdown
-10.9%
Largest decline past year
52-Week Range
$39-$52
Price range past year
Annual Return
+29.8%
Cumulative gain past year
| Period | OHI Return | S&P 500 |
|---|---|---|
| 1m | +5.7% | -0.7% |
| 3m | +7.3% | +2.9% |
| 6m | +14.9% | +7.2% |
| 1y | +29.8% | +16.9% |
| ytd | +13.2% | +8.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OHI Fundamental Analysis
Revenue is growing strongly, with the most recent quarter (Q1 2026) reporting $323.0 million, up 16.7% year-over-year. This marks an acceleration from the prior year's quarterly revenues, which ranged from $276.8 million to $321.8 million. The growth is driven by rent escalations and portfolio expansion, with the U.S. skilled nursing segment being the primary contributor. The company is highly profitable, with net income of $151.0 million in Q1 2026 and a net margin of 46.8%. Gross margin is exceptionally high at 97.2%, typical for a triple-net lease REIT where tenants cover property expenses. Operating margin of 64.1% reflects efficient cost management, though interest expense of $49.8 million weighs on pre-tax income. The balance sheet is healthy: debt-to-equity is 0.82, and the current ratio of 3.46 indicates ample liquidity. Free cash flow (TTM) is $907.1 million, providing strong coverage for the dividend (payout ratio of 132.2% on net income, but FCF covers dividends). ROE of 11.4% is solid for a REIT, and the company generates sufficient cash to fund growth internally.
Quarterly Revenue
$322955000.0B
2026-03
Revenue YoY Growth
+16.7%
YoY Comparison
Gross Margin
97.2%
Latest Quarter
Free Cash Flow
$907053000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OHI Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 21.95x, while the forward P/E is 25.43x, implying the market expects earnings growth. The gap between trailing and forward P/E suggests modest growth expectations, consistent with the REIT's stable but moderate earnings trajectory. Compared to the industry average (REIT - Healthcare Facilities), Omega's trailing P/E of 21.95x is at a premium to the sector median of approximately 18x (based on available data). This premium is justified by the company's superior net margin (46.8% vs. industry average ~30%) and strong revenue growth. Historically, Omega's trailing P/E has ranged from 9.9x (Q1 2022) to 52.8x (Q4 2021). The current 21.95x is near the middle of this range, suggesting the stock is fairly valued relative to its own history. The PEG ratio of 0.77 indicates the stock is undervalued relative to its growth rate, supporting a bullish valuation view.
PE
22.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 10x~46x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Omega's high dividend payout ratio of 132.2% on net income is a key risk, as it suggests earnings may not fully cover dividends. However, TTM free cash flow of $907.1M provides better coverage. Interest expense of $49.8M in Q1 2026 is a significant fixed cost, and any rise in interest rates could pressure net income. Revenue concentration in skilled nursing facilities exposes the company to sector-specific downturns, such as changes in Medicare/Medicaid reimbursement rates. The debt-to-equity ratio of 0.82 is manageable but not negligible, and the current ratio of 3.46 indicates ample liquidity.
Market & Competitive Risks: The stock trades at a trailing P/E of 21.95x, a premium to the industry median of ~18x, which could lead to valuation compression if growth disappoints. The stock's beta of 0.57 reduces market correlation but also means it may underperform in strong bull markets. Competitive risks include other healthcare REITs like Welltower and Ventas, which may offer better diversification. Recent news highlights operator credit concerns in the sector, as seen with Medical Properties Trust, though Omega's portfolio is more focused on skilled nursing. The wide analyst target range ($45-$63) reflects uncertainty about operator performance and macro conditions.
Worst-Case Scenario: A severe recession could lead to declining occupancy rates and operator defaults, forcing Omega to reduce rents or write down assets. This could trigger dividend cuts and a sharp stock decline. The 52-week low of $38.23 represents a potential -26.1% downside from the current price of $51.72. In a worst-case scenario, the stock could fall to the analyst low target of $45.00 (-13.0%) or even lower if operator credit issues materialize. Historical max drawdown of -10.86% (likely from recent highs) suggests moderate downside, but a sector-wide crisis could exceed that.
FAQ
The primary risk is operator credit quality; any defaults or rent reductions could impact income. The high payout ratio (132.2%) means the dividend is not fully covered by net income, though FCF provides coverage. Interest expense of $49.8M per quarter is sensitive to rate changes. Additionally, the stock's concentration in skilled nursing facilities exposes it to regulatory changes in Medicare/Medicaid. Finally, the stock's proximity to its 52-week high limits upside potential. The most severe risk is a dividend cut, which could lead to a significant price decline.
Analysts have a consensus Buy rating with an average target of $50.89, implying slight downside from the current $51.72. The bull case (25% probability) targets $55-$63, driven by occupancy improvements and lower rates. The base case (55% probability) targets $48-$55, assuming modest growth and stable dividends. The bear case (20% probability) targets $38-$45, factoring in operator stress or a dividend cut. The most likely scenario is the base case, with the stock trading in a range around current levels. Key catalysts include the next earnings report and interest rate decisions.
Omega's trailing P/E of 21.95x is a premium to the industry median of ~18x, suggesting it is slightly overvalued relative to peers. However, the PEG ratio of 0.77 indicates undervaluation when factoring in earnings growth. Historically, the P/E has ranged from 9.9x to 52.8x, and the current level is near the middle, implying fair value. The market is pricing in stable growth and a high dividend, but the premium may be justified by Omega's superior net margin (46.8%) and strong FCF. Overall, the stock appears fairly valued with a slight premium for quality.
Omega Healthcare Investors offers a compelling income play with a 5.94% dividend yield and strong revenue growth of 16.7% YoY. However, the stock is near its 52-week high ($51.92) and analyst targets average $50.89, implying slight downside. The PEG ratio of 0.77 suggests undervaluation relative to growth, but the high payout ratio (132.2%) is a concern. For income-focused investors with a long-term horizon, OHI could be a good buy on pullbacks, especially if the stock dips to the $45-$48 range. Growth-oriented investors may find better opportunities elsewhere given the limited near-term upside.
Omega Healthcare Investors is best suited for long-term investment due to its stable dividend yield (5.94%) and low volatility (beta 0.57). The stock's 32.6% gain over the past year suggests short-term momentum, but the near-term upside is limited given the stock is at its 52-week high. For short-term traders, the stock may offer limited opportunities unless a pullback occurs. A minimum holding period of 3-5 years is recommended to benefit from dividend compounding and potential growth. The company's strong FCF and solid balance sheet support long-term dividend sustainability.